| Clonal architecture of CXCR4 WHIM‐like mutations in Waldenström Macroglobulinaemia L Xu, ZR Hunter, N Tsakmaklis, Y Cao, G Yang, J Chen, X Liu, S Kanan, ... British journal of haematology 172 (5), 735-744, 2016 | 143 | 2016 |
| Ibrutinib-associated rash: a single-centre experience of clinicopathological features and management. DJ Iberri, BY Kwong, LA Stevens, SE Coutre, J Kim, JM Sabile, RH Advani British Journal of Haematology 180 (1), 2018 | 54 | 2018 |
| Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation EC Liang, SE Dekker, JMG Sabile, S Torelli, A Zhang, K Miller, P Shiraz, ... Blood Advances 7 (14), 3395-3402, 2023 | 9 | 2023 |
| KLHL6 is preferentially expressed in germinal center–derived B-cell lymphomas CA Kunder, G Roncador, RH Advani, G Gualco, CE Bacchi, JM Sabile, ... American journal of clinical pathology 148 (6), 465-476, 2017 | 8 | 2017 |
| Clinical predictors for thrombus progression in cirrhotic patients with untreated splanchnic vein thrombosis H McMurry, JMG Sabile, B Elstrott, B Chobrutskiy, A Mohinani, S Patel, ... Thrombosis research 216, 1-7, 2022 | 6 | 2022 |
| Ibrutinib-associated rash: single-center experience of clinicopathologic features and management DJ Iberri, B Kwong, L Stevens, SE Coutre, J Kim, J Sabile, RH Advani Blood 126 (23), 4860, 2015 | 5 | 2015 |
| A retrospective validation of the IPSS-M molecular score in primary and therapy-related myelodysplastic syndromes (MDS) JMG Sabile, A Kaempf, K Tomic, GP Manu, R Swords, Y Migdady Leukemia & lymphoma 64 (10), 1689-1694, 2023 | 4 | 2023 |
| Ultra-sensitive next-generation sequencing establishes the prognostic value of very low MRD in adults with acute lymphoblastic leukemia undergoing hematopoietic cell … EC Liang, SE Dekker, JMG Sabile, S Torelli, A Zhang, K Miller, P Shiraz, ... Blood 140 (Supplement 1), 1732-1733, 2022 | 4 | 2022 |
| Posterior reversible encephalopathy syndrome (PRES) and drug-induced hypersensitivity syndrome (DIHS) following immunotherapy and BRAF/MEK inhibition with continued response in … JM Sabile, DJ Grider, KA Prickett, L Hu, PV Mallidi Case Reports in Oncological Medicine 2021, 1-5, 2021 | 4 | 2021 |
| Correlation of 18-fluorodeoxyglucose PET/computed tomography parameters and clinical features to predict outcome for diffuse large B-cell lymphoma L Baratto, F Wu, R Minamimoto, N Hatami, T Liang, J Sabile, RH Advani, ... Nuclear Medicine Communications 42 (7), 792-799, 2021 | 3 | 2021 |
| Primary bone marrow epithelioid hemangioendothelioma treated with gemcitabine and docetaxel JMG Sabile, MS Stump, FC Fitzpatrick, MR Skelton JCO Oncology Practice 17 (2), 118-120, 2021 | 3 | 2021 |
| A retrospective validation study comparing the IPSS-M and IPSS-R risk stratification scores in primary and secondary myelodysplastic syndrome (MDS) JMG Sabile, A Kaempf, K Tomic, G Manu, RT Swords, Y Migdady Blood 140 (Supplement 1), 4088-4089, 2022 | 1 | 2022 |
| Evaluating targeted therapies in older patients with TP53-mutated AML JMG Sabile, R Swords, JW Tyner Leukemia & Lymphoma, 1-18, 2024 | | 2024 |
| Discordance between Next Generation Sequencing and BCR-ABL PCR Measurable Residual Disease in Adult Patients with Ph+ Acute Lymphoblastic Leukemia SE Dekker, J Sabile, B Dasilva, C Saygin, M Schwartz, HS Raman, ... Blood 142, 6061, 2023 | | 2023 |
| Estrogen‐based hormonal therapy and the risk of thrombosis in COVID‐19 patients C LaVasseur, R Mathews, JSH Wang, K Martens, HS McMurry, S Peress, ... European Journal of Haematology 111 (5), 678-686, 2023 | | 2023 |
| POSTER: MDS-009 Enhanced Survival of Chronic Myelomonocytic Leukemia (CMML)-Dysplastic Over the Proliferative Subtype After Allogeneic Hematopoietic Cell Transplantation: A … H Niehus, J Sabile, RT Maziarz, G Meyers, R Cook, A Gandhi, JN Saultz, ... Clinical Lymphoma Myeloma and Leukemia 23, S180, 2023 | | 2023 |
| MDS-009 Enhanced Survival of Chronic Myelomonocytic Leukemia (CMML)-Dysplastic Over the Proliferative Subtype After Allogeneic Hematopoietic Cell Transplantation: A Tertiary … H Niehus, J Sabile, RT Maziarz, G Meyers, R Cook, A Gandhi, JN Saultz, ... Clinical Lymphoma Myeloma and Leukemia 23, S351-S352, 2023 | | 2023 |
| Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes: The Current Landscape and Future Directions J Sabile, S Pavletic, Y Migdady The Cancer Journal 29 (3), 179-187, 2023 | | 2023 |
| A Retrospective Validation Study Comparing the IPSS-M and IPSS-R Risk Stratification Scores in Primary and Secondary Myelodysplastic Syndrome (MDS) JMG Sabile, A Kaempf, K Tomic, G Manu, R Swords, Y Migdady 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | | 2023 |
| Pre-Transplant Measurable Residual Disease By Next-Generation Sequencing Is a Better Predictor of Relapse Compared to BCR-ABL PCR in Adult Patients with Ph+ Acute Lymphoblastic … SE Dekker, JMG Sabile, EC Liang, BA DaSilva, S Torelli, A Kaempf, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | | 2023 |
Lori Mufflystanford universityVerified email at stanford.edu
